Events

Tandem Diabetes Care’s symposium held during the 2022 ISPAD conference in Abu Dhabi (UAE) highlights the pediatric glycemic outcomes of the t:slim X2 insulin pump with Control-IQ technology. Dr. Marc Breton revealed the outcomes of the PEDAP randomized clinical trial in children ages 2-5. Dr. Amelie Poidvin reviewed the sustained glycemic control after 2 years of the school-aged FreeLife Kids cohort. And Dr. Laurel Messer reviewed the results of Control-IQ in the adolescent population.

On April 27th, at the ATTD conference in Barcelona, Spain a panel of scientists and practitioners discussed successful clinical outcomes and real-world data of the t:slim X2 insulin pump with Control-IQ Technology. Discussion was based on real-world experience across a variety of patient age groups, irrespective of prior insulin therapy.

On October 13th, scientists and clinicians who have been closely involved in the development and launch of Control-IQ™ technology for the t:slim X2™ insulin pump discussed patient selection and benefits in the pediatric population at the ISPAD 2021 Virtual Conference. Discussion included recent clinical data and patient-reported outcomes. Time was set aside at the end for a live question and answer session.

On September 28th, scientists and clinicians who have been closely involved in the development and launch of Control-IQ® technology for the t:slim X2™ insulin pump discussed patient selection in the era of advanced hybrid closed-loop systems at the EASD 2021 Virtual Conference. This presentation includes best practices for your clinic and recent patient reported outcomes. Time was set aside at the end for a live question and answer session.

Join Dr. Jordan Pinsker from Tandem Diabetes Care to learn more about the latest real-world data and review case studies about the onboarding experience with the t:slim X2 ™ insulin pump with Control-IQ ® technology.

Watch our sponsored presentation which was featured on Friday, July 16th at the Practical Ways to Achieve Targets in Diabetes Care (ATDC) Keystone Conference 2021. Here, Jordan Pinsker, MD and Harsimran Singh, PhD of Tandem Diabetes Care present, “Glycemic and Psychosocial Achievements with Control-IQ Advanced Hybrid Closed-Loop Technology" and answer questions from a live audience.

Join Marc Breton, PhD from the University of Virginia and Steph Habif, EdD MS with Tandem Diabetes Care, to learn more about data published by Diabetes Technology and Therapeutics (DTT)on the latest real-world results on one year use of the t:slim X2™ insulin pump with Control-IQ® technology. Dr. Breton will discuss one-year real-world study results from 9,451 Control-IQ technology users, and Dr.Habif will cover quality-of-life outcomes and glycemic control from the ongoing Control-IQ Observational (CLIO) Study of 700 participants, which aims to evaluate real-world use of the t:slim X2 insulin pump with Control-IQ technology in diverse groups of people with type 1 diabetes.

Christina Pamelar, Product Manager of Clinical Solutions, hosts this webinar featuring Drs. Marc Breton, PhD and Harsimran Singh PhD, as they discuss real-world data reporting following patients using the t:slim X2™ insulin pump with Control-IQ™ technology.

Originally presented at the ATTD 2021 Virtual Conference, this symposium features Jordan Pinsker, MD, Marc Breton, PhD and Harsimran Singh, PhD while they discuss activities, reported patient impact, and clinical outcomes of t:slim X2 Insulin Pump with Control-IQ technology.

Join Laurel Messer, PhD, RN, CDCES, Assistant Professor of Pediatrics at the Barbara Davis Center for Childhood Diabetes and the University of Colorado School of Medicine, to learn more about practical tools to help understand diabetes management utilizing the t:slim X2™ with Control-IQ® technology. The webinar will discuss her recently published article, “Initiating Hybrid Closed Loop: A Program Evaluation of an Educator-Led Control-IQ Follow-up at a Large Pediatric Clinic.” The presentation will be followed by a speaker Q&A.

Join Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, to learn more about the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes. This webinar will cover the study results of the pivotal trial and a pediatric case study. The presentation will be followed by a speaker Q&A.

Join Christina Pamelar, Product Manager, and Erica Page, Sales and Clinical Training Manager, at Tandem Diabetes Care to help your patients on the t:slim X2™ insulin pump with Control-IQ® technology understand their data and outcomes on Tandem's t:connect® web application. This webinar will review guidelines for evaluating t:connect® reports data; assess pump settings, and review case study examples from t:connect reports. The presentation will be followed by a speaker Q&A.

Originally featured during the virtual ISPAD 2020 conference, this corporate symposium features moderator Peter Adolfsson, MD, PhD, University of Gothenburg, Marc Breton, PhD, University of Virginia, Laya Ekhlaspour, MD, Stanford University, and Eric Renard, MD, PhD, University of Montpellier.

Originally featured on during the European Association for the Study of Diabetes (EASD) Annual Meeting 2020, this corporate symposium features moderator Steph Habif, EdD, MS, Tandem Diabetes Care, Marc Breton, PhD, University of Virginia, and R. Paul Wadwa, MD, Barbara Davis Center.

Introducing the t:slim X2 insulin pump with Control-IQ Technology